[Special Stock] Green Cross Rises on Earnings Growth Outlook from US Blood Bank Acquisition

Green Cross is showing strong performance on expectations of growth through the acquisition of a U.S. blood bank.

As of 9:32 a.m. on the 12th, Green Cross is trading at 174,800 KRW, up 11.76% from the previous day.

Green Cross announced yesterday that it acquired all shares of ABO Holdings for approximately 138 billion KRW to expand its U.S. plasma fractionation business. The scheduled date of share acquisition is January 31 next year.

Kim Min-jung, a researcher at DS Investment & Securities, said, "Green Cross plans to undergo a post-merger integration (PMI) process with ABO Holdings starting next year," adding, "The full-scale expansion of blood supply will be applied from 2026." She further predicted, "AliGlo sales in 2026 will rise significantly to about 353.3 billion KRW."